Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

This study is currently recruiting participants.

Verified February 2013 by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Sponsor:

Information provided by (Responsible Party):

Giuseppe Procopio, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

ClinicalTrials.gov Identifier:

NCT01444807

First received: September 8, 2011

Last updated: March 6, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2016
Estimated Primary Completion Date:	September 2015 (Final data collection date for primary outcome measure)